Schonfeld Strategic Advisors’s Kiniksa Pharmaceuticals KNSA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.9M | Buy |
68,751
+18,904
| +38% | +$523K | 0.01% | 932 |
|
|
2025
Q1 | $1.11M | Buy |
49,847
+21,447
| +76% | +$476K | 0.01% | 1129 |
|
|
2024
Q4 | $562K | Sell |
28,400
-60,900
| -68% | -$1.2M | ﹤0.01% | 1283 |
|
|
2024
Q3 | $2.23M | Buy |
89,300
+909
| +1% | +$22.7K | 0.01% | 714 |
|
|
2024
Q2 | $1.65M | Sell |
88,391
-128,517
| -59% | -$2.4M | 0.01% | 875 |
|
|
2024
Q1 | $4.28M | Sell |
216,908
-9,543
| -4% | -$188K | 0.03% | 587 |
|
|
2023
Q4 | $3.97M | Buy |
226,451
+17,951
| +9% | +$315K | 0.03% | 524 |
|
|
2023
Q3 | $3.62M | Buy |
208,500
+134,070
| +180% | +$2.33M | 0.03% | 547 |
|
|
2023
Q2 | $1.05M | Buy |
74,430
+9,432
| +15% | +$133K | 0.01% | 938 |
|
|
2023
Q1 | $699K | Buy |
64,998
+14,998
| +30% | +$161K | 0.01% | 1051 |
|
|
2022
Q4 | $749K | Buy |
+50,000
| New | +$749K | 0.01% | 1299 |
|
|
2020
Q3 | – | Sell |
-15,900
| Closed | -$405K | – | 1465 |
|
|
2020
Q2 | $405K | Buy |
+15,900
| New | +$405K | 0.01% | 840 |
|
|
2020
Q1 | – | Sell |
-38,900
| Closed | -$430K | – | 1331 |
|
|
2019
Q4 | $430K | Buy |
+38,900
| New | +$430K | 0.01% | 813 |
|